XML 67 R51.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity (Narrative) (Details) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Apr. 02, 2020
Dec. 31, 2020
Nov. 25, 2020
Mar. 29, 2020
Oct. 28, 2019
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Feb. 11, 2020
Jan. 17, 2018
Jan. 16, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Common stock, shares authorized   50,000,000         50,000,000 50,000,000   50,000,000 200,000,000
Common stock, shares issued   25,085,534         25,085,534 5,582,280      
Common stock, shares outstanding   25,085,534         25,085,534 5,582,280      
Preferred stock, shares authorized   10,000,000         10,000,000 10,000,000      
Preferred stock, shares issued   0         0 0      
Preferred stock, shares outstanding   0         0 0      
Proceeds from issuance of common stock, net of issuance costs             $ 15,821,922 $ 4,782,509      
Stock options, granted             1,525,000      
Share-based compensation, tax benefit from compensation expense             $ 1,300,000        
Employee service share-based compensation, non-vested awards, compensation cost not yet recognized, period for recognition             3 years 1 month 6 days        
Share-based compensation arrangement by share-based payment award, options, vested in period, fair value             $ 549,341 $ 375,789      
Restricted Stock Units [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Employee service share-based compensation, non-vested awards, compensation cost not yet recognized, period for recognition             1 year 3 months 19 days        
Employee service share-based compensation, non-vested awards, compensation cost not yet recognized, total   $ 49,000         $ 49,000        
2015 Plan [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Share-based compensation arrangement by share-based payment award, number of shares authorized   2,710         2,710        
Share-based compensation arrangement by share-based payment award, description             the number of shares that have been authorized for issuance under the 2015 Plan will be automatically increased on the first day of each fiscal year beginning on January 1, 2016 and ending on (and including) January 1, 2025, in an amount equal to the lesser of (1) 4% of the outstanding shares of common stock on the last day of the immediately preceding fiscal year, or (2) another lesser amount determined by the Company’s Board of Directors.        
Share-based compensation arrangement by share-based payment award, number of shares available for grant   6,025         6,025        
Share-based compensation arrangement by share-based payment award, common stock percentage             4.00%        
2016 Stock Option Plan [Member] | Replacement Awards [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Weighted average grant date fair value of options awarded             $ 1.68        
Number of share options granted             134,371        
Curetis GmbH [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Acquisition of shares 2,028,208                    
ExecutiveOfficers And Non-Employee Directors [Member] | 2020 Stock Options Plan [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Common shares available for future issuance amount           $ 1,300,000          
Stock options, granted           1,300,000          
Common Stock [Member] | H.C. Wainwright & Co., LLC [Member] | 2020 ATM Offering [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Stock issued during period, shares, new issues             7,521,610        
Proceeds from issuance of common stock, net of issuance costs             $ 15,800,000        
Gross proceeds from sale of common stock             16,700,000        
Remaining availability under market offering             5,400,000        
Common Stock [Member] | H.C. Wainwright & Co., LLC [Member] | 2020 ATM Offering [Member] | Maximum [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Common shares available for future issuance amount                 $ 22,100,000    
March 2019 Public Offering [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Stock issued during period, shares, new issues       450,000              
Proceeds from issuance of common stock, net of issuance costs       $ 4,800,000              
Gross proceeds from sale of common stock       $ 5,400,000              
Shares issued, price per share       $ 12.00              
October 2019 Public Offering [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Stock issued during period, shares, new issues         2,590,170            
Shares issued, price per share         $ 2.00            
Class of warrant or right, exercise price of warrants or rights         $ 2.00            
Warrants exercisable period         5 years            
October 2019 Public Offering [Member] | Common Warrants [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Proceeds from issuance of common stock, net of issuance costs             $ 8,700,000        
Warrants exercised   359,000         4,341,000        
October 2019 Public Offering [Member] | Common Stock [Member] | Placement Agent [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Class of warrant or right, exercise price of warrants or rights         $ 2.60            
Warrants exercisable period         5 years            
Issuance of common stock warrants to purchase         235,000            
October 2019 Public Offering [Member] | Pre-funded Units [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Stock issued during period, shares, new issues         2,109,830            
Shares issued, price per share         $ 1.99            
Gross proceeds from sale of common stock and warrants         $ 9,400,000            
Net proceeds from sale of common stock and warrants         $ 8,300,000            
Class of warrant or right, exercise price of warrants or rights         $ 0.01            
Warrants exercised               2,109,830      
October 2019 Public Offering [Member] | Pre Funded Warrant [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Warrants exercised         2,109,830            
2020 PIPE [Member] | Healthcare-focused U.S. Institutional Investor [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Stock issued during period, shares, new issues     2,245,400                
Proceeds from issuance of common stock, net of issuance costs     $ 9,300,000                
Gross proceeds from sale of common stock     $ 10,000,000                
Shares issued, price per share     $ 2.065                
Class of warrant or right, exercise price of warrants or rights     $ 1.94                
Warrants exercisable period     6 months                
Warrants exercised     4,842,615                
Issuance of common stock warrants to purchase     2,245,400                
Warrants expiry period     5 years 6 months                
2020 PIPE [Member] | Pre Funded Warrant [Member] | Healthcare-focused U.S. Institutional Investor [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Stock issued during period, shares, new issues     2,597,215                
Shares issued, price per share     $ 2.055                
Warrants exercised     2,597,215                
Issuance of common stock warrants to purchase     2,597,215